Detalles de la búsqueda
1.
A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study.
Cancer Epidemiol Biomarkers Prev
; 17(3): 594-604, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18349277
2.
Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: a Gynecologic Oncology Group study.
Gynecol Oncol
; 108(3): 493-9, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18191993
3.
Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study.
J Clin Oncol
; 26(20): 3418-25, 2008 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-18612157
Resultados
1 -
3
de 3
1
Próxima >
>>